En español
NIDA

Menu

Mexico

Binational Agreements

NIDA has signed letters of understanding to cooperate on biomedical and behavioral drug abuse research with the following institutions:

France:

Italy:

Mexico:

Mexican Officials Honor CTN Florida Node Alliance for Collaboration

The Instituto Nacional de Psiquiatria Ramón de la Fuente (NIP) of Mexico recently honored Viviana Horigian, Ph.D., University of Miami, and her research colleagues at the NIDA Clinical Trials Network (CTN) Florida Node Alliance (FNA). NIP Director María Elena Medina-Mora, Ph.D., presented the award April 16, 2013, during a ceremony celebrating the first randomized clinical trial completed through a recently formed Mexican network based on the CTN model, which teams substance abuse and mental health researchers with community treatment providers.

Former DISCA Awardee and Colleagues Report Changes in Mexican Controls Reduced Methamphetamine Potency, Harm in United States

Former NIDA International Program Distinguished International Scientist Octavio Campollo, M.D., M.Sci., Ph.D., Mexico, and colleagues report in Drug and Alcohol Dependence that Mexico’s 2004 controls on ephedrine and pseudoephedrine changed the U.S. methamphetamine market. Restrictions on these precursor chemicals in Mexico resulted in widespread emergence of less potent methamphetamine and declines in prevalence and availability of the most potent type of the drug, which had dominated the U.S. market since the late 1980s. The authors found that U.S.

Letter Calls for Increased Research on Inhalants

Members of the NIDA International Program Inhalant Working Group have published a letter in the Canadian Journal of Public Health [103(6): 473] calling for increased qualitative and quantitative research on inhalant abuse. The letter cites recent findings that inhalants are often the first substance misused by young people, use among girls is increasing, and volatile substances are being marketed in parts of Mexico with the addition of appealing odorants, such as cinnamon or coconut.

Drug Abuse Prevention Research Fellowship Trains "Next Generation" of Mexican Prevention Research Scientists

As the first U.S.–Mexico Drug Abuse Prevention Research Fellow, Argentina Servin, M.D., says she feels very responsible for learning everything possible during the fellowship and applying her knowledge in her home country. She works with commercial sex workers (CSWs), injection drug users (IDUs), and their children to break the cycle of drug use and sex-for-drugs that contributes to the HIV epidemic in northern Mexico. “Even my colleagues working in Tijuana and Ciudad Juarez are astonished at the number of young people affected by CSW/IDU parents and environments,” Dr. Servin said.

Mexico City Meeting Spurs Local, International Action on Inhalant Abuse

A September 2012 international meeting in Mexico City that focused on inhalant abuse featured presentations by members of the NIDA International Program Inhalant Working Group (IWG) and has already begun yielding results. El Instituto para la Atención y Prevención de las Adicciones en la Ciudad de México (IAPA) hosted the meeting, which attracted more than 200 policymakers, researchers, service providers, and industry representatives. Former NIDA INVEST Fellow and IWG member Silvia Cruz, Ph.D., Cinvestav, chaired the scientific program. NIDA Acting Deputy Director David A.

Mexican Scientist Awarded New Prevention Fellowship

Argentina Elisa N. Servin Aguirre, M.D., has been named the first U.S.–Mexico Drug Abuse Prevention Research Fellow. The new fellowship is a collaborative effort of NIDA and the National Institute of Psychiatry Ramón de la Fuente Muñiz, along with participation from the National Commission Against Addictions (CONADIC) and the Society for Prevention Research.

New Fellowship Opportunity for Mexican Postdoctoral Scientists

A new fellowship program will enable talented Mexican postdoctoral scientists to devote 12 months to drug abuse prevention research in the United States.

NIDA and the Mexican National Institute of Psychiatry Ramón de la Fuente Muñiz (NIP), along with the Mexican National Commission Against Addictions (CONADIC) and the Society for Prevention Research, have established the United States–Mexico Drug Abuse Prevention Research Fellowship.

Steffanie Strathdee, Ph.D.; María Remedios Lozada Romero, M.D., Mexico; and Carlos Magis-Rodríguez, M.D., M.P.H., Mexico

Steffanie A. Strathdee, Ph.D.
Department of Medicine
University of California San Diego School of Medicine
San Diego, California, United States
and
María Remedios Lozada Romero, M.D.
HIV/STD Coordinator
Baja California State
Tijuana, Mexico
and
Carlos Magis-Rodríguez, M.D., M.P.H.
Department of Research
CENSIDA
Mexico City, Mexico

Researchers Attend Meeting on the Basic Parent Management Training-Oregon Model

NIDA supported the participation of two U.S. researchers at a November 23–27, 2010, meeting in Mexico City on the Basic Parent Management Training-Oregon (PMTO) Model. The meeting was organized by Dr. Maria Elena Medina-Mora Icaza, Mexican National Institute of Psychiatry, “Dr. Ramón de la Fuente Múñiz,” to advance the binational research project, Development and Implementation of a Training Model in Positive Parenting Practices in Mexican Families With Children Who Present Behavior Problems.

Pages

Subscribe to Mexico

Important Dates

NIDA International Program Fellowships

Application Deadlines:
Postdoctoral Fellowships:
April 1

Meetings

July 13 - July 18, 2014
Montreal, Quebec, Canada
July 20 - July 25, 2014
Melbourne, Australia
August 1 - August 1, 2014
Cold Spring Harbor, New York, USA